Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for RDOR3.SA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RDOR3.SA and 80,000+ other tickers.
See exactly how RDOR3.SA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RDOR3.SA and 80,000+ other tickers.
Rede D'Or São Luiz S.A. manages an extensive healthcare network across Brazil. The company delivers a comprehensive range of medical services, covering areas such as neurology, oncology, and pathology, alongside specialized treatments for hemangioma, lymphangioma, lymphatic malformation, and various vascular anomalies and tumors. Its offerings also include advanced vascular surgery, radiology, and interventional radiology. For younger patients, it provides expert care in pediatric cardiology, oncology, hematology, and surgery. This extensive enterprise comprises 51 wholly-owned hospitals, one…
No recent news available.